Actionable news
All posts from Actionable news
Actionable news in BLUE: bluebird bio, Inc.,

Maxim Weighs In On Bluebird Bio Inc Following Investors Meeting With Management

Maxim’s healthcare analyst Jason McCarthy weighed in today with an optimistic view on bluebird bio Inc (NASDAQ:BLUE), after spending an evening with bluebird management and clients, discussing everything from the ongoing LentiGlobin trials in beta-thalassemia and sickle cell disease to the pricing debate and expansion to oncology.

McCarthy wrote, “While the BTK index has seen “a correction”, bluebird management is not concerned. With a billion in cash, including the strategic takedown of $500M at the market peak in June...